Cobenfy offers an alternative that addresses symptoms of schizophrenia with a different approach. The U.S. Food and Drug Administration (FDA) recently approved Cobenfy (xanomeline and trospium chloride) for…
Read MoreCobenfy offers an alternative that addresses symptoms of schizophrenia with a different approach. The U.S. Food and Drug Administration (FDA) recently approved Cobenfy (xanomeline and trospium chloride) for…
Read More